Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-11-30

Clinical Trial Update: A Trial to Assess Safety and Efficacy of ADO09 Versus Insulin Aspart in Subjects With Type 1 Diabetes Mellitus [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for ADO09 vs insulin aspart in Type 1 Diabetes Mellitus (Phase 1/Phase 2) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ADO09
  • Insulin aspart (insulin aspart)

Snippet

Sponsor: Adocia | Conditions: Type 1 Diabetes Mellitus | Phase 1, Phase 2 | Status: COMPLETED